# Depemokimab (Genetical Recombination) S.C. Injection 100mg Pen (エキシデンサー皮下注１００ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2290404G2026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2290404G2026
- **Product name (Japanese):** エキシデンサー皮下注１００ｍｇペン
- **English title:** Depemokimab (Genetical Recombination) S.C. Injection 100mg Pen
- **Active ingredient:** デペモキマブ（遺伝子組換え）
- **Active ingredient (INN):** Depemokimab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ１ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 22 Respiratory agents (呼吸器官用薬) › 229 Other respiratory agents (その他の呼吸器官用薬)
- **Manufacturer:** GlaxoSmithKline (グラクソ・スミスクライン)
- **NHI price (reference only):** JPY 1143284 per １００ｍｇ１ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2290404G2026
- **JSON:** https://www.nifujipharma.com/api/drugs/2290404G2026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Depemokimab%20(Genetical%20Recombination)%20S.C.%20Injection%20100mg%20Pen%20(%E3%82%A8%E3%82%AD%E3%82%B7%E3%83%87%E3%83%B3%E3%82%B5%E3%83%BC%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%202290404G2026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Depemokimab (Genetical Recombination)

- [Depemokimab (Genetical Recombination) S.C. Injection 100mg Syringe (エキシデンサー皮下注１００ｍｇシリンジ)](https://www.nifujipharma.com/drugs/2290404G1020) — １００ｍｇ１ｍＬ１筒, GlaxoSmithKline
